open access

Vol 74, No 6 (2023)
Review paper
Submitted: 2023-06-28
Accepted: 2023-08-18
Published online: 2023-11-09
Get Citation

Thyroid disease and autoimmunity in obese patients: a narrative review

Francesca Bambini1, Elisa Gatta1, Rossella D'Alessio2, Francesco Dondi3, Giusto Pignata2, Ilenia Pirola1, Francesco Bertagna3, Carlo Cappelli1
·
Pubmed: 37994585
·
Endokrynol Pol 2023;74(6).
Affiliations
  1. Department of Clinical and Experimental Sciences, SSD Endocrinologia, University of Brescia, Azienda Socio-Sanitaria Territoriale (ASST) Spedali Civili di Brescia, Brescia, Italy
  2. Department of General Surgery 2, ASST Spedali Civili di Brescia, Italy
  3. Nuclear Medicine, University of Brescia, ASST Spedali Civili di Brescia, Italy

open access

Vol 74, No 6 (2023)
Review Article
Submitted: 2023-06-28
Accepted: 2023-08-18
Published online: 2023-11-09

Abstract

Introduction: The high prevalence of obesity and thyroid diseases worldwide justifies di per se their simultaneous coexistence. In recent decades, there has been a parallel and significant rise in obesity and thyroid diseases in industrialised countries, although the underlying mechanisms are complex and not well known.

Material and methods: The authors accomplished a comprehensive literature search of original articles concerning obesity and thyroid status. Original papers exploring the association between these two morbidities in children and adults were included.

Results: A total of 79 articles were included in the present analysis. A total of 12% of obese children (mean age 10.9 ± 1.4 years) showed a thyroid disease, and they were younger than healthy obese children (10.9 ± 1.2 vs. 11.0 ± 0.4 years, p < 0.001). Isolated hyperthyrotropinaemia was the most frequent finding in children (10.1%). Autoimmune thyroid disease was more frequent in puberal age. Thyroid antibodies and subclinical hypothyroidism were more frequent in obese that in non-obese patients (7% vs. 3%, p < 0.001; 10% vs. 6%, p < 0.001). Among obese adults, 62.2% displayed a thyroid disease; those affected were younger (35.3 ± 6.8 vs. 41.0 ± 1.9 years, p < 0.001), heavier [body mass index (BMI): 39.4 ± 6.3 vs. 36.1 ± 2.3 kg/m2, p < 0.001], and more frequently female (13% vs. 8%, p < 0.001). The most frequent disease was overt hypothyroidism (29.9%). BMI appears to be correlated with TSH levels in obese adults. Overt hypothyroidism was significantly more frequent in obese patients (7% vs. 3%, p < 0.005), but no difference was found in thyroid antibodies (15% vs. 14%, p = 0.178).

Conclusions: An undeniable relationship between obesity and thyroid impairments exists. Isolated hyperthyrotropinaemia is frequently seen in obese children, often followed by spontaneous resolution. Subclinical hypothyroidism should never be treated in children or adults with the aim of reducing body weight.

Abstract

Introduction: The high prevalence of obesity and thyroid diseases worldwide justifies di per se their simultaneous coexistence. In recent decades, there has been a parallel and significant rise in obesity and thyroid diseases in industrialised countries, although the underlying mechanisms are complex and not well known.

Material and methods: The authors accomplished a comprehensive literature search of original articles concerning obesity and thyroid status. Original papers exploring the association between these two morbidities in children and adults were included.

Results: A total of 79 articles were included in the present analysis. A total of 12% of obese children (mean age 10.9 ± 1.4 years) showed a thyroid disease, and they were younger than healthy obese children (10.9 ± 1.2 vs. 11.0 ± 0.4 years, p < 0.001). Isolated hyperthyrotropinaemia was the most frequent finding in children (10.1%). Autoimmune thyroid disease was more frequent in puberal age. Thyroid antibodies and subclinical hypothyroidism were more frequent in obese that in non-obese patients (7% vs. 3%, p < 0.001; 10% vs. 6%, p < 0.001). Among obese adults, 62.2% displayed a thyroid disease; those affected were younger (35.3 ± 6.8 vs. 41.0 ± 1.9 years, p < 0.001), heavier [body mass index (BMI): 39.4 ± 6.3 vs. 36.1 ± 2.3 kg/m2, p < 0.001], and more frequently female (13% vs. 8%, p < 0.001). The most frequent disease was overt hypothyroidism (29.9%). BMI appears to be correlated with TSH levels in obese adults. Overt hypothyroidism was significantly more frequent in obese patients (7% vs. 3%, p < 0.005), but no difference was found in thyroid antibodies (15% vs. 14%, p = 0.178).

Conclusions: An undeniable relationship between obesity and thyroid impairments exists. Isolated hyperthyrotropinaemia is frequently seen in obese children, often followed by spontaneous resolution. Subclinical hypothyroidism should never be treated in children or adults with the aim of reducing body weight.

Get Citation

Keywords

obesity; thyroid; hypothyroidism; hyperthyroidism; autoimmune thyroid diseases

Supp./Additional Files (1)
Supplementary File
Download
30KB
About this article
Title

Thyroid disease and autoimmunity in obese patients: a narrative review

Journal

Endokrynologia Polska

Issue

Vol 74, No 6 (2023)

Article type

Review paper

Published online

2023-11-09

Page views

683

Article views/downloads

273

DOI

10.5603/ep.96255

Pubmed

37994585

Bibliographic record

Endokrynol Pol 2023;74(6).

Keywords

obesity
thyroid
hypothyroidism
hyperthyroidism
autoimmune thyroid diseases

Authors

Francesca Bambini
Elisa Gatta
Rossella D'Alessio
Francesco Dondi
Giusto Pignata
Ilenia Pirola
Francesco Bertagna
Carlo Cappelli

References (141)
  1. WHO. Obesity. https://www.who.int/health-topics/obesity#tab=tab_1.
  2. Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016; 22(7 Suppl): s176–s185.
  3. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258): 1204–1222.
  4. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87(2): 489–499.
  5. Walsh JP, Bremner AP, Feddema P, et al. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010; 95(3): 1095–1104.
  6. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43(1): 55–68.
  7. Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160(4): 526–534.
  8. Aoki Y, Belin RM, Clickner R, et al. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007; 17(12): 1211–1223.
  9. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977; 7(6): 481–493.
  10. Romagnani S, Romagnani S, Parronchi P, et al. Immune mechanisms in the pathogenesis of inflammatory gastrointestinal disorders. Ital J Gastroenterol. 1996; 28 Suppl 2(46 Suppl): 11–17.
  11. Orgiazzi J. Thyroid autoimmunity. Presse Med. 2012; 41(12): e611–e625.
  12. Antonelli A, Ferrari SM, Corrado A, et al. Autoimmune thyroid disorders. Autoimmun Rev. 2015; 14(2): 174–180.
  13. Diana T, Olivo PD, Kahaly GJ. Thyrotropin Receptor Blocking Antibodies. Horm Metab Res. 2018; 50(12): 853–862.
  14. Williams DE, Le SN, Godlewska M, et al. Thyroid Peroxidase as an Autoantigen in Hashimoto's Disease: Structure, Function, and Antigenicity. Horm Metab Res. 2018; 50(12): 908–921.
  15. McLachlan S, Rapoport B. Thyroid Peroxidase as an Autoantigen. Thyroid. 2007; 17(10): 939–948.
  16. Godlewska M, Banga PJ. Thyroid peroxidase as a dual active site enzyme: Focus on biosynthesis, hormonogenesis and thyroid disorders of autoimmunity and cancer. Biochimie. 2019; 160: 34–45.
  17. Le SN, Porebski BT, McCoey J, et al. Modelling of Thyroid Peroxidase Reveals Insights into Its Enzyme Function and Autoantigenicity. PLoS One. 2015; 10(12): e0142615.
  18. van Hulsteijn LT, Pasquali R, Casanueva F, et al. Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. Eur J Endocrinol. 2020; 182(1): 11–21.
  19. Poddar M, Chetty Y, Chetty VT. How does obesity affect the endocrine system? A narrative review. Clin Obes. 2017; 7(3): 136–144.
  20. Tsigalou C, Vallianou N, Dalamaga M. Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity? Curr Obes Rep. 2020; 9(3): 245–254.
  21. Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155(8): 529–536.
  22. Stichel H, l'Allemand D, Grüters A. Thyroid function and obesity in children and adolescents. Horm Res. 2000; 54(1): 14–19.
  23. Bhowmick SK, Dasari G, Levens KL, et al. The prevalence of elevated serum thyroid-stimulating hormone in childhood/adolescent obesity and of autoimmune thyroid diseases in a subgroup. J Natl Med Assoc. 2007; 99(7): 773–776.
  24. Marwaha RK, Tandon N, Garg MK, et al. Impact of body mass index on thyroid functions in Indian children. Clin Endocrinol (Oxf). 2013; 79(3): 424–428.
  25. Ghergherehchi R, Hazhir N. Thyroid hormonal status among children with obesity. Ther Adv Endocrinol Metab. 2015; 6(2): 51–55.
  26. Dündar İ, Akıncı A. The Frequency of Subclinical Hypothyroidism in Obese Children and Adolescents and Its Relationship with Metabolic Parameters and Atherogenic Index. Turk Arch Pediatr. 2022; 57(3): 316–322.
  27. Marras V, Casini MR, Pilia S, et al. Thyroid function in obese children and adolescents. Horm Res Paediatr. 2010; 73(3): 193–197.
  28. Grandone A, Santoro N, Coppola F, et al. Thyroid function derangement and childhood obesity: an Italian experience. BMC Endocr Disord. 2010; 10: 8.
  29. Eliakim A, Barzilai M, Wolach B, et al. Should we treat elevated thyroid stimulating hormone levels in obese children and adolescents? Int J Pediatr Obes. 2006; 1(4): 217–221.
  30. Di Sessa A, Cembalo Sambiase Sanseverino N, De Simone RF, et al. Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity. J Endocrinol Invest. 2023; 46(9): 1835–1842.
  31. Dursun F, Atasoy Öztürk T, Seymen Karabulut G, et al. Obesity-related thyroiditis in childhood: relationship with insulin resistance. J Pediatr Endocrinol Metab. 2019; 32(5): 471–478.
  32. Dahl M, Ohrt JD, Fonvig CE, et al. Subclinical Hypothyroidism in Danish Lean and Obese Children and Adolescents. J Clin Res Pediatr Endocrinol. 2017; 9(1): 8–16.
  33. Ruszała A, Wójcik M, Starzyk JB. The impact of thyroid function on the occurrence of metabolic syndrome in obese children and adolescents. Pediatr Endocrinol Diabetes Metab. 2019; 25(1): 1–5.
  34. Bouglé D, Morello R, Brouard J. Thyroid function and metabolic risk factors in obese youth. Changes during follow-up: a preventive mechanism? Exp Clin Endocrinol Diabetes. 2014; 122(9): 548–552.
  35. Dekelbab BH, Abou Ouf HA, Jain I. Prevalence of elevated thyroid-stimulating hormone levels in obese children and adolescents. Endocr Pract. 2010; 16(2): 187–190.
  36. Patel R, Dave C, Mehta S, et al. Metabolic Impact of Subclinical Hypothyroidism in Obese Children and Adolescents. Indian J Pediatr. 2021; 88(5): 437–440.
  37. Özcabı B, Tarçın G, Şengenç E, et al. Is Waist-height Ratio Associated with Thyroid Antibody Levels in Children with Obesity? J Clin Res Pediatr Endocrinol. 2021; 13(2): 152–159.
  38. García-García E, Vázquez-López MA, García-Fuentes E, et al. Thyroid Function and Thyroid Autoimmunity in Relation to Weight Status and Cardiovascular Risk Factors in Children and Adolescents: A Population-Based Study. J Clin Res Pediatr Endocrinol. 2016; 8(2): 157–162.
  39. Thiagarajan S, Arun Babu T, Balaji R. Subclinical Hypothyroidism in Obese South Indian Children. Indian J Pediatr. 2019; 86(7): 662.
  40. Jin HY. Prevalence of subclinical hypothyroidism in obese children or adolescents and association between thyroid hormone and the components of metabolic syndrome. J Paediatr Child Health. 2018; 54(9): 975–980.
  41. Matusik P, Gawlik A, Januszek-Trzciakowska A, et al. Isolated Subclinical Hyperthyrotropinemia in Obese Children: Does Levothyroxine (LT4) Improve Weight Reduction during Combined Behavioral Therapy? Int J Endocrinol. 2015; 2015: 792509.
  42. Krause AJ, Cines B, Pogrebniak E, et al. Associations between adiposity and indicators of thyroid status in children and adolescents. Pediatr Obes. 2016; 11(6): 551–558.
  43. Dayal D, Kumar TS. High Prevalence of Thyroid Dysfunction in Children with Simple Obesity. Indian Pediatr. 2019; 56(4): 331.
  44. Ittermann T, Thamm M, Schipf S, et al. Relationship of smoking and/or passive exposure to tobacco smoke on the association between serum thyrotropin and body mass index in large groups of adolescents and children. Thyroid. 2013; 23(3): 262–268.
  45. Kumar S, Dayal D, Attri S, et al. Levothyroxine supplementation for obesity-associated thyroid dysfunction in children: a prospective, randomized, case control study. Pediatr Endocrinol Diabetes Metab. 2019; 25(3): 107–113.
  46. Zhang B, Wang J, Shen S, et al. Subclinical hypothyroidism is not a risk factor for polycystic ovary syndrome in obese women of reproductive age. Gynecol Endocrinol. 2018; 34(10): 875–879.
  47. Marzullo P, Minocci A, Tagliaferri MA, et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants. J Clin Endocrinol Metab. 2010; 95(8): 3965–3972.
  48. Zhu C, Gao J, Mei F, et al. Reduction in Thyroid-Stimulating Hormone Correlated with Improved Inflammation Markers in Chinese Patients with Morbid Obesity Undergoing Laparoscopic Sleeve Gastrectomy. Obes Surg. 2019; 29(12): 3954–3965.
  49. Granzotto PC, Mesa Junior CO, Strobel R, et al. Thyroid function before and after Roux-en-Y gastric bypass: an observational study. Surg Obes Relat Dis. 2020; 16(2): 261–269.
  50. Moulin de Moraes CM, Mancini MC, de Melo ME, et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg. 2005; 15(9): 1287–1291.
  51. Xia MF, Chang XX, Zhu XP, et al. Preoperative Thyroid Autoimmune Status and Changes in Thyroid Function and Body Weight After Bariatric Surgery. Obes Surg. 2019; 29(9): 2904–2911.
  52. Janssen IMC, Homan J, Schijns W, et al. Subclinical hypothyroidism and its relation to obesity in patients before and after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015; 11(6): 1257–1263.
  53. Abdelbaki TN, Elkeleny MR, Sharaan MA, et al. Impact of Laparoscopic Sleeve Gastrectomy on Obese Patients with Subclinical Hypothyroidism. J Laparoendosc Adv Surg Tech A. 2020; 30(3): 236–240.
  54. Walczak K, Siemińska L. The relationships between selected serum adipokines and thyroid function in patients with obesity. Endokrynol Pol. 2022; 73(2): 353–360.
  55. Mahdavi M, Amouzegar A, Mehran L, et al. Investigating the prevalence of primary thyroid dysfunction in obese and overweight individuals: Tehran thyroid study. BMC Endocr Disord. 2021; 21(1): 89.
  56. Sami A, Iftekhar MF, Rauf MA, et al. Subclinical Hypothyroidism among local adult obese population. Pak J Med Sci. 2018; 34(4): 980–983.
  57. Asvold BO, Bjøro T, Vatten LJ. Association of serum TSH with high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab. 2009; 94(12): 5023–5027.
  58. Han C, Li C, Mao J, et al. High Body Mass Index Is an Indicator of Maternal Hypothyroidism, Hypothyroxinemia, and Thyroid-Peroxidase Antibody Positivity during Early Pregnancy. Biomed Res Int. 2015; 2015: 351831.
  59. Wang B, Song R, He W, et al. Sex Differences in the Associations of Obesity With Hypothyroidism and Thyroid Autoimmunity Among Chinese Adults. Front Physiol. 2018; 9: 1397.
  60. Sharma M, Modi A, Goyal M, et al. Anti-thyroid antibodies and the gonadotrophins profile (LH/FSH) in euthyroid polycystic ovarian syndrome women. Acta Endocrinol (Buchar). 2022; 18(1): 79–85.
  61. Bedaiwy MA, Abdel-Rahman MY, Tan J, et al. Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study. J Womens Health (Larchmt). 2018; 27(5): 659–664.
  62. Nayak PK, Mitra S, Sahoo J, et al. Relationship of subclinical hypothyroidism and obesity in polycystic ovarian syndrome patients. J Family Med Prim Care. 2020; 9(1): 147–150.
  63. Rimm AA, Werner LH, Yserloo BV, et al. Relationship of ovesity and disease in 73,532 weight-conscious women. Public Health Rep. 1975; 90(1): 44–51.
  64. Fierabracci P, Basolo A, Scartabelli G, et al. Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity. J Endocrinol Invest. 2022; 45(11): 2077–2084.
  65. Walczak K, Sieminska L. Obesity and Thyroid Axis. Int J Environ Res Public Health. 2021; 18(18).
  66. Yan Y, Xu M, Wu M, et al. Obesity is associated with subclinical hypothyroidism in the presence of thyroid autoantibodies: a cross-sectional study. BMC Endocr Disord. 2022; 22(1): 94.
  67. Yang H, Xia Q, Shen Y, et al. Gender-Specific Impact of Metabolic Obesity Phenotypes on the Risk of Hashimoto's Thyroiditis: A Retrospective Data Analysis Using a Health Check-Up Database. J Inflamm Res. 2022; 15: 827–837.
  68. Yao JY, Liu P, Zhang W, et al. Obesity rather than Metabolic Syndrome is a Risk Factor for Subclinical Hypothyroidism and Thyroid Autoimmunity. Biomed Environ Sci. 2021; 34(10): 819–823.
  69. Mousa U, Bozkuş Y, Kut A, et al. Fat distribution and metabolic profile in subjects with Hashimoto's thyroiditis. Acta Endocrinol (Buchar). 2018; 14(1): 105–112.
  70. Agbaht K, Mercan Y, Kutlu S, et al. Obesity with and without metabolic syndrome: do vitamin D and thyroid autoimmunity have a role? Diabetes Res Clin Pract. 2014; 106(1): 27–34.
  71. Ağbaht K, Pişkinpaşa SV. Serum TSH, 25(OH) D and phosphorus levels predict weight loss in individuals with diabetes/prediabetes and morbid obesity: a single-center retrospective cohort analysis. BMC Endocr Disord. 2022; 22(1): 282.
  72. Răcătăianu N, Leach N, Bondor CI, et al. Thyroid disorders in obese patients. Does insulin resistance make a difference? Arch Endocrinol Metab. 2017; 61(6): 575–583.
  73. Răcătăianu N, Leach NV, Bolboacă SD, et al. Vitamin D deficiency, insulin resistance and thyroid dysfunction in obese patients: is inflammation the common link? Scand J Clin Lab Invest. 2018; 78(7-8): 560–565.
  74. Wu Y, Shi X, Tang X, et al. The Correlation Between Metabolic Disorders And Tpoab/Tgab: A Cross-Sectional Population-Based Study. Endocr Pract. 2020; 26(8): 869–882.
  75. Valdés S, Maldonado-Araque C, Lago-Sampedro A, et al. Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study. Obesity (Silver Spring). 2017; 25(4): 788–793.
  76. Kang C, Liu J, Zheng Y, et al. Association of high BMI with subclinical hypothyroidism in young, first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study. Eur Arch Psychiatry Clin Neurosci. 2023; 273(1): 183–190.
  77. Chikunguwo S, Brethauer S, Nirujogi V, et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis. 2007; 3(6): 631–5; discussion 635.
  78. Neves JS, Souteiro P, Oliveira SC, et al. AMTCO Group. Preoperative thyroid function and weight loss after bariatric surgery. Int J Obes (Lond). 2019; 43(2): 432–436.
  79. Almunif DS, Bamehriz F, Althuwaini S, et al. The Effect of Laparoscopic Sleeve Gastrectomy on Serum Thyroid-Stimulating Hormone Levels in Obese Patients with Overt and Subclinical Hypothyroidism: a 7-Year Retrospective Study. Obes Surg. 2020; 30(4): 1491–1497.
  80. Gniuli D, Leccesi L, Guidone C, et al. Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion. Obes Surg. 2010; 20(1): 61–68.
  81. Ruiz-Tovar J, Boix E, Galindo I, et al. Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure. Obes Surg. 2014; 24(5): 791–795.
  82. Dewantoro D, Davenport R, Goh JYi, et al. The Effect of Different Types of Bariatric Surgery on Levothyroxine Requirement in Hypothyroid Bariatric Patients. Cureus. 2022; 14(6): e26165.
  83. Pedro J, Cunha F, Souteiro P, et al. The Effect of the Bariatric Surgery Type on the Levothyroxine Dose of Morbidly Obese Hypothyroid Patients. Obes Surg. 2018; 28(11): 3538–3543.
  84. Zendel A, Abu-Ghanem Y, Dux J, et al. The Impact of Bariatric Surgery on Thyroid Function and Medication Use in Patients with Hypothyroidism. Obes Surg. 2017; 27(8): 2000–2004.
  85. Wang B, Shao X, Song R, et al. The Emerging Role of Epigenetics in Autoimmune Thyroid Diseases. Front Immunol. 2017; 8: 396.
  86. Makwane H, Kare P, Saxena T, et al. Relationship between Thyroid Hormones and Body Mass Index in Healthy Indian Adults. J Clin Diag Res. 2020.
  87. Hemminki K, Li X, Sundquist J, et al. Risk of asthma and autoimmune diseases and related conditions in patients hospitalized for obesity. Ann Med. 2012; 44(3): 289–295.
  88. Ornaghi S, Algeri P, Todyrenchuk L, et al. Impact of excessive pre-pregnancy body mass index and abnormal gestational weight gain on pregnancy outcomes in women with chronic hypertension. Pregnancy Hypertens. 2018; 12: 90–95.
  89. Zendel A, Abu-Ghanem Y, Dux J, et al. The Impact of Bariatric Surgery on Thyroid Function and Medication Use in Patients with Hypothyroidism. Obes Surg . 2017; 27(8): 2000–2004.
  90. Raftopoulos Y, Gagné DJ, Papasavas P, et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2004; 14(4): 509–513.
  91. Khan WF, Singla V, Aggarwal S, et al. Outcome of bariatric surgery on hypothyroidism: experience from a tertiary care center in India. Surg Obes Relat Dis. 2020; 16(9): 1297–1301.
  92. Sundaram U, McBride C, Shostrom V, et al. Prevalence of Preoperative Hypothyroidism in Bariatric Surgery Patients and Postoperative Change in Thyroid Hormone Requirements. Bariatric Surg Pract Patient Care. 2013; 8(4): 147–151.
  93. Rudnicki Y, Slavin M, Keidar A, et al. The effect of bariatric surgery on hypothyroidism: Sleeve gastrectomy versus gastric bypass. Surg Obes Relat Dis. 2018; 14(9): 1297–1303.
  94. Szomstein S, Avital S, Brasesco O, et al. Laparoscopic gastric bypass in patients on thyroid replacement therapy for subnormal thyroid function - prevalence and short-term outcome. Obes Surg. 2004; 14(1): 95–97.
  95. Kapelari K, Kirchlechner C, Högler W, et al. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocr Disord. 2008; 8: 15.
  96. Giannakopoulos A, Lazopoulou N, Pervanidou P, et al. The Impact of Adiposity and Puberty on Thyroid Function in Children and Adolescents. Child Obes. 2019; 15(6): 411–415.
  97. Dunger DB, Perkins JA, Jowett TP, et al. A longitudinal study of total and free thyroid hormones and thyroxine binding globulin during normal puberty. Acta Endocrinol (Copenh). 1990; 123(3): 305–310.
  98. Murer SB, Knöpfli BH, Aeberli I, et al. During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat. J Clin Endocrinol Metab. 2010; 95(12): 5412–5418.
  99. Reinehr T, Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child. 2002; 87(4): 320–323.
  100. Reinehr T, de Sousa G, Andler W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab. 2006; 91(8): 3088–3091.
  101. Reinehr T, Isa A, de Sousa G, et al. Thyroid hormones and their relation to weight status. Horm Res. 2008; 70(1): 51–57.
  102. Shalitin S, Yackobovitch-Gavan M, Phillip M. Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters. Horm Res. 2009; 71(3): 155–161.
  103. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010; 316(2): 165–171.
  104. Légrádi G, Emerson CH, Ahima RS, et al. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology. 1997; 138(6): 2569–2576.
  105. Reinehr T. Thyroid function in the nutritionally obese child and adolescent. Curr Opin Pediatr. 2011; 23(4): 415–420.
  106. Burman KD, Latham KR, Djuh YY, et al. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab. 1980; 51(1): 106–116.
  107. D'Adamo E, De Leonibus C, Giannini C, et al. Thyroid dysfunction in obese pre-pubertal children: oxidative stress as a potential pathogenetic mechanism. Free Radic Res. 2012; 46(3): 303–309.
  108. Calcaterra V, Nappi RE, Regalbuto C, et al. Gender Differences at the Onset of Autoimmune Thyroid Diseases in Children and Adolescents. Front Endocrinol (Lausanne). 2020; 11: 229.
  109. Brown MA, Su MA. An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses. J Immunol. 2019; 202(7): 1927–1933.
  110. Moulton VR. Sex Hormones in Acquired Immunity and Autoimmune Disease. Front Immunol. 2018; 9: 2279.
  111. Trombetta AC, Meroni M, Cutolo M. Steroids and Autoimmunity. Front Horm Res. 2017; 48: 121–132.
  112. Baranowska-Bik A, Bik W. The Association of Obesity with Autoimmune Thyroiditis and Thyroid Function-Possible Mechanisms of Bilateral Interaction. Int J Endocrinol. 2020; 2020: 8894792.
  113. Divella R, De Luca R, Abbate I, et al. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer. 2016; 7(15): 2346–2359.
  114. StatPearls. StatPearls Publishing, Treasure Island 2023.
  115. Karampela I, Christodoulatos GS, Dalamaga M. The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox. Curr Obes Rep. 2019; 8(4): 434–457.
  116. Longhi S, Radetti G. Thyroid function and obesity. J Clin Res Pediatr Endocrinol. 2013; 5(Suppl 1): 40–4.
  117. Aversa T, Valenzise M, Corrias A, et al. Underlying Hashimoto's thyroiditis negatively affects the evolution of subclinical hypothyroidism in children irrespective of other concomitant risk factors. Thyroid. 2015; 25(2): 183–187.
  118. Wasniewska M, Aversa T, Salerno M, et al. Five-year prospective evaluation of thyroid function in girls with subclinical mild hypothyroidism of different etiology. Eur J Endocrinol. 2015; 173(6): 801–808.
  119. Trigunaite A, Dimo J, Jørgensen TN. Suppressive effects of androgens on the immune system. Cell Immunol. 2015; 294(2): 87–94.
  120. Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 1979; 22(11): 1188–1194.
  121. Lengi AJ, Phillips RA, Karpuzoglu E, et al. Estrogen selectively regulates chemokines in murine splenocytes. J Leukoc Biol. 2007; 81(4): 1065–1074.
  122. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003; 24(5): 694–717.
  123. Chiovato L, Larizza D, Bendinelli G, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol. 1996; 134(5): 568–575.
  124. Karlsson B, Gustafsson J, Hedov G, et al. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child. 1998; 79(3): 242–245.
  125. Boukis MA, Koutras DA, Souvatzoglou A, et al. Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab. 1983; 57(4): 859–862.
  126. Wu Q, Rayman MP, Lv H, et al. Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease. J Clin Endocrinol Metab. 2015; 100(11): 4037–4047.
  127. Fukata S, Kuma K, Sugawara M. Relationship between cigarette smoking and hypothyroidism in patients with Hashimoto's thyroiditis. J Endocrinol Invest. 1996; 19(9): 607–612.
  128. Asvold BO, Bjøro T, Nilsen TIL, et al. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007; 167(13): 1428–1432.
  129. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995; 332(20): 1351–1362.
  130. Pekary AE, Hershman JM. Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I- symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology. 1998; 139(2): 703–712.
  131. Gajda SN, Kuryłowicz A, Żach M, et al. Diagnosis and treatment of thyroid disorders in obese patients - what do we know? Endokrynol Pol. 2019; 70(3): 271–276.
  132. LeFevre ML. U.S. Preventive Services Task Force. Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015; 162(9): 641–650.
  133. Pasquali R, Casanueva F, Haluzik M, et al. European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity. Eur J Endocrinol. 2020; 182(1): G1–G32.
  134. Ong KK, Kuh D, Pierce M, et al. Medical Research Council National Survey of Health and Development Scientific and Data Collection Teams. Childhood weight gain and thyroid autoimmunity at age 60-64 years: the 1946 British birth cohort study. J Clin Endocrinol Metab. 2013; 98(4): 1435–1442.
  135. Holm IA, Manson JE, Michels KB, et al. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Arch Intern Med. 2005; 165(14): 1606–1611.
  136. Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005; 90(7): 4019–4024.
  137. Gopinath B, Wang J, Kifley A, et al. Five-year Incidence and Progression of Thyroid Dysfunction in an Older Population. Intern Med J. 2010; 40(9): 642–649.
  138. Somwaru LL, Arnold AM, Cappola AR. Predictors of thyroid hormone initiation in older adults: results from the cardiovascular health study. J Gerontol A Biol Sci Med Sci. 2011; 66(7): 809–814.
  139. Amouzegar A, Ghaemmaghami Z, Beigy M, et al. Natural Course of Euthyroidism and Clues for Early Diagnosis of Thyroid Dysfunction: Tehran Thyroid Study. Thyroid. 2017; 27(5): 616–625.
  140. Zhao S, Tang Li, Fu J, et al. Subclinical Hypothyroidism and Sperm DNA Fragmentation: A Cross-sectional Study of 5401 Men Seeking Infertility Care. J Clin Endocrinol Metab. 2022; 107(10): e4027–e4036.
  141. Alourfi Z, Hijazi N, Alsultan M. Association of subclinical hypothyroidism with metabolic syndrome components in a group of apparently healthy Syrians: a retrospective cross-sectional study. Ann Med Surg (Lond). 2023; 85(4): 670–675.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl